Natera Reports Third-Quarter 2026 Financial Results
Natera reported total revenue of $794.0 million for the third quarter ended September 30, 2026.
Story updates
09:06:21 PM UTC
SquawkNews
Natera reported Q3 2026 revenue of $794.0M, up 34.1% from $592.2M a year earlier, and a net loss of $59.9M, or $0.42 per diluted share, versus $87.5M, or $0.64, in Q3 2025. It anticipates 2026 revenue of $3.005B—$3.035B and positive cash flow.Material DetailsContext by AI AnalystThis is a quarterly…
09:14:30 PM UTC
SquawkNews
Natera reported third-quarter 2026 revenue of $794.0 million, up 34.1% year over year, and a net loss of $59.9 million. Gross margin was 64.7%, while diluted loss per share was $0.42. The company raised its 2026 revenue guidance to $3.005 billion to $3.035 billion.Financial HighlightsBusiness Highl…
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the third quarter ended September 30, 2026.Recent Financial HighlightsThird Quarter Ended September 30, 2026 Financial ResultsTotal revenues were $794.0 million in the third…